Expertise

• Advising Smurfit Kappa Group plc on its $25.5 billion merger with WestRock Company to form Smurfit Westrock.
• Advising Horizon Therapeutics on all aspects of its proposed acquisition by Amgen for aggregate consideration of $28 billion.
• Advising Smurfit Kappa Group on its €660 million Share Placing.
• Advising Willis Towers Watson plc on all aspects of its pending $80 billion business combination with Aon plc, to be effected by means of an Irish law scheme of arrangement.
• Advising Orpea S.A. on all aspects of its acquisition of the TLC group of nursing homes.
• Advising various issuers and banks on equity capital markets transactions across a broad range of markets (NYSE, NASDAQ, LSE, Euronext Dublin, Euronext Growth, ASX).
• Advising a number of Irish, NYSE and NASDAQ listed companies on their respective takeovers by way of scheme of arrangement or general offer under the Irish Takeover Rules.
• Advising a FTSE 100 company on its acquisition by public tender of a 30% minority interest in a listed company.
• Advising an existing listed company on its US$74 billion merger of equals and concurrent redomiciliation to Ireland.
• Advising two existing listed companies on their redomiciliations to Ireland via European cross-border merger.
• Advising a FTSE 100 company on its successful response to unsolicited takeover offers under the Irish Takeover Rules.
• Advising various issuers on a number of issuances of secured and unsecured debt. 

Admitted as a solicitor in Ireland

University College Dublin, (BCL)

University College Dublin, Master of Laws (Commercial)